A promising and recently emerged biomarker for ALS might be tau phosphorylated at threonine 181 (p-Tau181), which is present at higher levels in the plasma of patients with ALS than in that of healthy controls. This evidence concerns the gene MAPT and amyotrophic lateral sclerosis.